Host Immunity and Vaccines for Respiratory Pathogens
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: 31 January 2026 | Viewed by 5
Special Issue Editors
Interests: human vaccines; human immunity; epidemiology and health statistics; health economics
Interests: human vaccines; infectious disease modelling; epidemiology and health statistics; social contact; human mobility
Special Issue Information
Dear Colleagues,
We invite researchers to contribute to an upcoming Special Issue of Vaccines focusing on “Host Immunity and Vaccines for Respiratory Pathogens”. Respiratory infections, including influenza, RSV, SARS-CoV-2, and emerging pathogens, remain a global health challenge. This Special Issue aims to explore advances in understanding host–pathogen interactions, immune evasion mechanisms, and innovations in vaccine design, evaluation, and deployment.
We welcome original research articles, reviews, and clinical studies addressing topics such as the following:
- Innate/adaptive immune responses to respiratory pathogens;
- Novel vaccine platforms (mRNA, viral vectors, etc.) and adjuvants;
- Correlates of protection and vaccine efficacy in diverse populations;
- Mucosal immunity and respiratory tract-targeted strategies;
- Challenges in vaccine equity and pandemic preparedness;
- Real world effectiveness of human vaccines.
Submissions will undergo rigorous peer review, and selected papers will highlight cutting-edge science with translational impact. By sharing your insights, you will contribute to shaping future vaccine strategies against respiratory diseases.
We encourage early submissions to ensure timely consideration. Join us in advancing knowledge to combat respiratory pathogens and safeguard global health.
Dr. Hanqing He
Dr. Yuxia Liang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccines
- immunity
- infectious disease
- respiratory pathogens
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
